Kala Pharmaceuticals
Earnings Surprise
Analysts estimated KALA earnings of $-1.47 per share this quarter (Q4). KALA's actual earnings were $-0.67 per share.
KALA EPS surprise of 54.38%Analysts estimated KALA earnings of $-1.47 per share this quarter (Q3). KALA's actual earnings were $-0.86 per share.
KALA EPS surprise of 41.67%Analysts estimated KALA earnings of $-2.07 per share this quarter (Q1). KALA's actual earnings were $-1.41 per share.
KALA EPS surprise of 31.90%Analysts estimated KALA earnings of $-2.07 per share this quarter (Q4). KALA's actual earnings were $-1.41 per share.
KALA EPS surprise of 31.90%Analysts estimated KALA earnings of $-2.48 per share this quarter (Q3). KALA's actual earnings were $-1.93 per share.
KALA EPS surprise of 22.13%Analysts estimated KALA earnings of $-4.49 per share this quarter (Q2). KALA's actual earnings were $-3.16 per share.
KALA EPS surprise of 29.67%Analysts estimated KALA earnings of $-2.95 per share this quarter (Q1). KALA's actual earnings were $-4.19 per share.
KALA EPS surprise of -42.14%Analysts estimated KALA earnings of $-3.69 per share this quarter (Q4). KALA's actual earnings were $-3.18 per share.
KALA EPS surprise of 16.11%Analysts estimated KALA earnings of $-2.20 per share this quarter (Q3). KALA's actual earnings were $-3.41 per share.
KALA EPS surprise of 55.16%